Many vaccine trials are underway worldwide to prevent the corona virus. In such a situation, there are some vaccines whose percentage is more than 90. Meanwhile, information has surfaced about the Corona vaccine (CoveShield) of Oxford University and the AstraZeneca company (Oxford-AstraZeneca coronavirus vaccine), with two full doses giving better immune responses. Let me tell you that Oxford University, after one full dose, its vaccine triggers a better immune response when given two whole doses than half the booster dose.
The university has issued a statement regarding this, which said that – First we tried a full and a half dose. That is, the candidate was given one and a half doses. Now two full doses were given. Their results were much better. A month ago, AstraZeneca and Oxford stated on the vaccine that, the vaccine’s booster dose produces stronger anti-antibody response than the single dose, with the standard dose / standard dose being the best response.
In the interim results of Oxford Vaccine, the vaccine was reported to be either 90% or 62% effective according to the dose strength. Scientists say that its average aphecy was 70%. But after some time, questions started being raised on this data. In the dose pattern up to 90% of which the vaccine was proving to be effective, the participants were given half the dose first, then a month later. It was found that the company did not think of giving half dose to any participant.
